Medicare Part D in 2026:
What Prescribers Need to Know
Wednesday, August 12th at 9 – 10 AM PT / 10 – 11 AM MT / 11AM – 12 PM CT / 12 – 1 PM ET
Duration 60 minutes
Description
Changes to Medicare rules, plan incentives, and financial responsibility can directly impact the prescribing of treatments for your patients. Part D plans can make it decidedly easier or harder to prescribe one medication versus another, and these practices can sometimes be grounded in financial considerations rather than clinical. Join us to learn how Part D plans may be responding to changes in Medicare, what you or your staff can do to minimize disruptions and delays if a Part D plan denies or delays coverage for the CLL treatment best suited to your patient. We will share practical steps you can take to navigate barriers and alert advocacy organizations like ours to take on the new and ongoing systemic barriers you and your office face.
Speakers
Speaker:
Saira Sultan, JD
President & CEO
Connect 4 Strategies
Director of Government Affairs & Public Policy
CLL Society
Speaker:
Kay Scanlan, JD
Principal
Consilium Strategies
Advance Questions
Please submit your advanced question(s) for the upcoming webinar by Monday, August 10th.
Questions that are clear, concise, and relevant to many participants are more likely to be selected by the moderator. Please avoid including detailed personal medical histories. All advanced questions submitted by the deadline provided will be shared with the speaker and moderator.
Find CLL Society on Social Media
Follow CLL Society on Facebook @CLLSociety as well as other social media platforms below.
This program was created in partnership with
CLL Society Resources
Virtual Exhibitor Resources